Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR)

CUSIP: 517125100

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 6 signals
Share change
-163,006
SEC-reported price per share
$14.61
Number of holders
53
Value change
-$8,290,625
Number of buys
25
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
107,502,422

Security key

517125100

Report period

Q1 2021

Institutions

53

Top holders

10

Ownership snapshot

Top reported holders of LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DEERFIELD MANAGEMENT COMP...
Disclosed value leader
DEERFIELD MANAGEMENT COMP...
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $110,145,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

DEERFIELD MANAGEMENT COMPANY, L.P. has the largest disclosed position value at $110.14M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DEERFIELD MANAGEMENT COMPANY, L.P.'s linked filing trail.
Disclosed position value Top 5
DEERFIELD MANAGEMENT COMPANY, L.P. $110.14M
RA CAPITAL MANAGEMENT, L.P. $32.44M
CHI Advisors LLC $32.44M
ORBIMED ADVISORS LLC $18.98M
ACUTA CAPITAL PARTNERS, LLC $18.48M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$110,145,000
5,144,539 shares
— 31 Dec 2020
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$32,439,000
1,515,151 shares
— 31 Dec 2020
CHI Advisors LLC
13F
Company
13F
—
denominator unverified
$32,439,000
1,515,148 shares
— 31 Dec 2020
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$18,981,000
886,560 shares
— 31 Dec 2020
ACUTA CAPITAL PARTNERS, LLC
13F
Company
13F
—
denominator unverified
$18,479,000
863,100 shares
— 31 Dec 2020
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$17,121,000
799,662 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
53
Shares
14,110,404
Rows available
53
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders
53
Q1 2021 holders
53
Holder diff
0
Investor Q1 2021 Shares Q1 2021 Shares Share Diff Share Chg % Q1 2021 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .